Systemic thrombolysis and anticoagulation improved biomarker measurements in massive-like pulmonary embolism and severe COVID-19 pneumonia: a case report.
Hector Betancourt-Del CampoCarlos Jerjes-SanchezMauricio Castillo-PerezHector López-de la GarzaJosé Gildardo Paredes-VázquezYoezer Z Flores-SayavedraFrancisco Moreno-Abril HoyosMarcos Ibarra-FloresPublished in: European heart journal. Case reports (2020)
Physicians in the ER should be warned about extremely high D-dimer measurements and severe oxygen desaturation as possible markers of severe COVID-19 pneumonia in patients with high-clinical suspicion of PE. Although ESC guidelines recommend immediate reperfusion in cardiogenic shock secondary to PE, we suggest initial CTPA in patients with high-clinical suspicion of severe COVID-19.
Keyphrases
- pulmonary embolism
- coronavirus disease
- sars cov
- early onset
- primary care
- acute ischemic stroke
- drug induced
- atrial fibrillation
- acute myocardial infarction
- acute coronary syndrome
- respiratory syndrome coronavirus
- cerebral ischemia
- blood brain barrier
- mechanical ventilation
- community acquired pneumonia
- breast cancer cells
- respiratory failure